Azalomycin F4
CAS: 81545-42-8
Ref. 3D-GDA54542
1mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued | ||
50mg | Discontinued |
Product Information
Azalomycin F4 is a potent kinase inhibitor that has been shown to inhibit the growth of cancer cells. It is derived from Chinese medicine and has been found to have significant anti-tumor activity in vitro. Azalomycin F4 targets kinases, which are enzymes involved in cell signaling and regulation. By inhibiting these kinases, Azalomycin F4 prevents the proliferation of cancer cells and induces apoptosis. This inhibitor has been tested on various human cancer cell lines, including mutant cell lines, and has shown promising results as a potential treatment for cancer. Its unique mechanism of action makes it an exciting prospect for future research in the field of oncology.